Catalyst Wire Dossier Catalyst Wire Dossier

Pigmentary Ti02

titanium dioxide pigment · Orfagen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pigmentary Ti02, covering 2014-03-31 to 2014-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU) [Phase 2]

See pricing